Get the Stockscreener App
11.75
9.89%
-1.29
Pre-market:
11.75
Adapthealth Corp stock is traded at $11.75, with a volume of 4.74M.
It is down -9.89% in the last 24 hours and down -2.33% over the past month.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
See More
Previous Close:
$13.04
Open:
$10.98
24h Volume:
4.74M
Relative Volume:
3.30
Market Cap:
$1.60B
Revenue:
$3.24B
Net Income/Loss:
$-66.64M
P/E Ratio:
-22.14
EPS:
-0.5308
Net Cash Flow:
$219.38M
1W Performance:
-12.18%
1M Performance:
-2.33%
6M Performance:
+13.64%
1Y Performance:
+35.06%
1-Day Range:
$10.80
$12.13
1-Week Range:
$10.80
$13.43
52-Week Range:
$7.95
$13.43
Adapthealth Corp Stock (AHCO) Company Profile
Name
Adapthealth Corp
Sector
Industry
Phone
610-424-4515
Address
555 EAST NORTH LANE, CONSHOHOCKEN, PA
Compare AHCO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AHCO
Adapthealth Corp
|
11.75 | 1.60B | 3.24B | -66.64M | 219.38M | -0.5308 |
ABT
Abbott Laboratories
|
87.17 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| May-10-23 | Downgrade | Deutsche Bank | Buy → Hold |
| May-10-23 | Downgrade | Stifel | Buy → Hold |
| May-09-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Jul-14-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-13-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-18-21 | Initiated | Truist | Buy |
| Jan-26-21 | Initiated | BofA Securities | Buy |
| Dec-10-20 | Initiated | UBS | Buy |
| Aug-10-20 | Initiated | Canaccord Genuity | Buy |
| Jul-01-20 | Resumed | SVB Leerink | Outperform |
| Jun-09-20 | Initiated | RBC Capital Mkts | Outperform |
| Jan-31-20 | Initiated | Stifel | Buy |
| Jan-07-20 | Initiated | Jefferies | Buy |
| Dec-11-19 | Initiated | SVB Leerink | Outperform |
| Dec-10-19 | Initiated | Deutsche Bank | Buy |
View All
Adapthealth Corp Stock (AHCO) Latest News
AHCO Q1 Deep Dive: Capitated Growth Boosts Revenue, Margin Pressures Persist - StockStory
AdaptHealth Q1 2026 slides: organic growth surges amid margin pressure By Investing.com - Investing.com South Africa
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 27, 2021AHCO - TMX Newsfile
AdaptHealth Corp. Q1 2026 Earnings Call Summary - Yahoo Finance
[10-Q] AdaptHealth Corp. Quarterly Earnings Report - Stock Titan
AdaptHealth Corp. to Participate in Upcoming Investor Conferences - The Joplin Globe
AdaptHealth schedules two investor fireside chats in May, with webcasts - Stock Titan
Why AdaptHealth (AHCO) Shares Are Sliding Today - StockStory
AdaptHealth Q1 2026 slides: organic growth surges amid margin pressure - Investing.com
AdaptHealth Q1 Earnings Call Highlights - Yahoo Finance
AdaptHealth sets stage for ‘defining year’ - HME News
Earnings call transcript: AdaptHealth Q1 2026 results miss EPS, stock drops - Investing.com
AdaptHealth Releases Q1 2026 Financial Results - AlphaStreet
AdaptHealth Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
AdaptHealth Seeks Acquisitions - marketscreener.com
AdaptHealth (NASDAQ:AHCO) Beats Q1 CY2026 Sales Expectations - TradingView
ADAPTHEALTH ($AHCO) Releases Q1 2026 Earnings - Quiver Quantitative
AdaptHealth falls on Q1 loss despite revenue beat By Investing.com - Investing.com Canada
AdaptHealth (NASDAQ: AHCO) Q1 2026 results, raises revenue outlook and names new COO - Stock Titan
AdaptHealth falls on Q1 loss despite revenue beat - Investing.com
AdaptHealth's 10 million-member rollout came with $12M in labor costs - Stock Titan
AdaptHealth Corp. Announces First Quarter 2026 Results - Caledonian Record
AdaptHealth (AHCO) Reports Earnings Tomorrow: What To Expect - Yahoo Finance UK
Adapthealth Corp stock hits 52-week high at $13.40 By Investing.com - Investing.com Australia
Adapthealth Corp stock hits 52-week high at $13.40 - Investing.com
AdaptHealth earnings up next: Can home health provider return to profit? - Investing.com UK
AdaptHealth earnings up next: Can home health provider return to profit? By Investing.com - Investing.com South Africa
AdaptHealth Corp (AHCO) Q1 2026 Earnings Report Preview: What To Look For - GuruFocus
Responsive Playbooks and the AHCO Inflection - Stock Traders Daily
AdaptHealth (NASDAQ:AHCO) Sets New 12-Month HighHere's What Happened - MarketBeat
Is It Time To Reassess AdaptHealth (AHCO) After A 60% One Year Rally? - simplywall.st
AdaptHealth (NASDAQ: AHCO) CTO corrects share count in Form 4/A filing - Stock Titan
AdaptHealth (AHCO) Expected to Announce Earnings on Tuesday - MarketBeat
AdaptHealth to Report First-Quarter 2026 Results on May 5 - MyChesCo
AdaptHealth refinances $1.1B senior secured credit facility - MSN
Adapthealth Corp stock hits 52-week high at 12.87 USD By Investing.com - Investing.com Australia
AdaptHealth Credit Upgrade And New US$1.1b Facility Reshape Outlook - Sahm
AdaptHealth (NASDAQ:AHCO) Hits New 52-Week HighStill a Buy? - MarketBeat
Adapthealth Corp stock hits 52-week high at 12.87 USD - Investing.com
New Credit Facility and Rating Upgrades Might Change The Case For Investing In AdaptHealth (AHCO) - simplywall.st
Strength or Weakness Analysis | AdaptHealth Corp posts $0.76 loss, 312.9% EPS missSocial Trade Signals - Xã Thanh Hà
Is AdaptHealth Corp (AHCO) Overvalued After 4.7% Rally? GF Value - GuruFocus
AdaptHealth to Join RBCCM Global Healthcare Conference with Fireside Chat - MSN
Understanding the Setup: (AHCO) and Scalable Risk - Stock Traders Daily
A Look At AdaptHealth (AHCO) Valuation After Recent Share Price Momentum - Sahm
AdaptHealth (AHCO) Stock: Trend Strength Analysis (Momentum Building) 2026-04-18Social Buy Zones - Cổng thông tin điện tử tỉnh Lào Cai
3 Reasons to Sell AHCO and 1 Stock to Buy Instead - Yahoo Finance
Form 8-KCurrent report - ADVFN
Notice of Pendency and Proposed Settlement of Class Action Announced in AdaptHealth Corp. Securities Litigation - Eastern Progress
AdaptHealth Corp. (NASDAQ:AHCO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
AdaptHealth Corp (AHCO) Shares Surge 3.7% -- What GF Score of 75 Tells Investors - GuruFocus
Adapthealth Corp Stock (AHCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Adapthealth Corp Stock (AHCO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| CASHIN RICHARD M JR | 10% Owner |
Mar 19 '26 |
Buy |
9.94 |
727 |
7,228 |
15,865,598 |
| Prast Albert A. | Chief Technology Officer |
Mar 13 '26 |
Option Exercise |
4.38 |
89,451 |
391,795 |
532,358 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 10 '26 |
Buy |
9.73 |
820,528 |
7,982,671 |
14,638,708 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 12 '26 |
Buy |
9.73 |
689,336 |
6,707,170 |
15,864,871 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 11 '26 |
Buy |
9.73 |
536,827 |
5,222,307 |
15,175,535 |
| WOLF DALE B | Director |
Feb 27 '26 |
Buy |
8.96 |
8,000 |
71,680 |
104,235 |
| Rew Richard W. II | CLO and General Counsel |
Feb 26 '26 |
Buy |
8.91 |
5,000 |
44,550 |
107,097 |
| Williams David Solomon III | Director |
Dec 04 '25 |
Sale |
9.43 |
5,000 |
47,150 |
45,045 |
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):